期刊文献+

维生素D及其受体基因遗传多态与结核病发病风险的关联研究 被引量:4

Vitamin D and polymorphisms of its receptor gene in association with the risk of tuberculosis
原文传递
导出
摘要 目的探讨血清维生素D水平及维生素D受体(vitamin D receptor,VDR)基因多态与结核病遗传易感性的关系。方法采用病例对照研究设计,病例来源于2008-2012年从江苏泰兴、镇江、武进、张家港、南京等地招募的活动性肺结核病人,共1 584例。对照组来自当地参加健康体检的居民,按年龄和性别与病例进行频数匹配,共1 566例。血清25-羟基维生素D的浓度检测采用艾狄斯TM25-羟基维生素D试剂盒,基因分型基于TaqMan分型技术。采用单因素和多因素Logistic回归模型计算比值比及其95%可信区间。结果病例组血清25-羟基维生素D浓度低于对照组,差异有统计学意义(Z=-11.28,P<0.001)。单位点分析发现,VDR基因上rs739837、rs757343和rs7975232位点基因多态与结核病的关联有统计学意义。与野生纯合子rs739837-GG基因型个体比较,携带变异纯合子TT基因型的个体患病风险下降约26%(调整OR=0.74,95%CI:0.55~0.99)。结论血清25-羟基维生素D水平及其代谢通路上的遗传多态与结核病的发病风险有关。 Objective To explore the serum vitamin D level and genetic polymorphisms of VDR gene in associa- tion with the susceptibility to tuberculosis. Methods A case-control study design was used. A total of 1 584 patients with active pulmonary tuberculosis were recruited from Taixing, Zhenjiang, Wujin, Zhangjiagang and Nanjing of Jiangsu from 2008 to 2012. 1 566 controls from a pool of individuals who participated in the local community-based health examination program were also recruited. Controls were frequency-matched to the cases by sex and age. Serum 25-hydroxyvitamin D concentration was measured by Aidisi 25-hydroxyvitamin D kit. Genotyping was performed by using TaqMan allelic discrim- ination technology. Univariate and multivariate logistic regression analysis were used to calculate odds ratio (OR) and 95% confidence interval (Cl). Results Serum 25-hydroxyvitamin D concentration in cases was lower than that of controls. The difference was statistically significant (P 〈 0. 001 ). Univariate analysis found that polymorphisms of rs739837, rs757343 and rs7975232 in VDR gene were significantly associated with the altered risk of tuberculosis. Compared with GG genotype of rs739837, the individuals carrying homozygous TT genotype had a 26% decreased risk ( adjusted OR = 0. 74, 95% CI: 0. 55-0. 99). Conclusions Serum 25-hydroxyvitamin D concentration and genetic polymorphisms of vitamin D metabolic pathway genes are associated with the risk of tuberculosis.
出处 《中华疾病控制杂志》 CAS 北大核心 2013年第10期895-899,共5页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(81072351) 江苏省科技支撑计划--社会发展(BE2011841) 江苏高校优势学科建设工程
关键词 维生素D 多态现象 遗传 结核 Vitamin D Polymorphism genetic Tuberculosis, pulmonary
  • 相关文献

参考文献22

  • 1罗惠文,丰燕,季明,常杰平,陆伟,许卫国,王建明.江苏某农村地区结核病患者疾病经济负担及其影响因素分析[J].中华疾病控制杂志,2012,16(10):877-880. 被引量:20
  • 2Martineau AR, Honecker FU, Wilkinson R J, et al. Vitamin D in the treatment of pulmonary tuberculosis [ J ]. J Steroid Biochem Mol Biol, 2007,103 (3-5) :793-798.
  • 3Sita-Lumsden A, Lapthorn G, Swaminathan R, et al. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight [ J ]. Thorax, 2007,62 ( 11 ) : 1003- 1007.
  • 4Yamshchikov AV, Desai NS, Blumberg HM, et al. Vitamin D for treatment and prevention of infectious diseases : a systematic review of randomized controlled trials [ J ]. Endocr Pract, 2009,15 ( 5 ) : 438-449.
  • 5Teuber M, Wenz MH, Schrciber S, et al. GMFilter and SXTest- Plate: software tools for improving the SNPlex genotyping system [ J]. BMC Bioinformatics, 2009,10:81.
  • 6Zerwekh JE. Blood biomarkers of vitamin D status [ J]. Am J Clin Nutr, 2008,87 (4) : 1087S-1091S.
  • 7Nnoahmn KE, Clarke A. Low serum vitamin D levels and tubercu-losis : a systematic review and recta-analysis [ J ]. Im J Epidemiol, 2008,37 ( 1 ) : 113-119.
  • 8Vieth R. Why " Vitamin D" is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids [ J ]. J Steroid Biochem Mol Biol, 2004,89 -90 ( 1-5 ) : 571-573.
  • 9李卫国(综述),李宇宁(审校).维生素D缺乏和人类疾病[J].国际儿科学杂志,2011,38(5):474-476. 被引量:21
  • 10Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer [J]. J Clin On- col, 2009,27 (23) :3757-3763.

二级参考文献90

共引文献54

同被引文献53

  • 1杨本付,韩长磊.维生素D受体基因多态性与肺结核关系的Meta分析[J].中国热带医学,2006,6(8):1347-1349. 被引量:16
  • 2陈雪融,冯玉麟,马玙,张宗德,李传友,文富强,唐晓燕,苏智广.维生素D受体基因多态性与中国藏族结核病的关联研究[J].四川大学学报(医学版),2006,37(6):847-851. 被引量:16
  • 3Friedman SL. Liver fibrosis -- from bench to bedside [ J]. J Hepa- tol, 2003,38( Suppl 1 ) :S38-S53.
  • 4Hemandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis [ J ]. Annu Rev Pathol, 2011, ( 6 ) :425-456.
  • 5Bouillon R. Genetic and environmental determinants of vitamin D status [J]. Lancet, 2010,376(9736):148-149.
  • 6Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease [ J]. J Hepatol, 2012, 57(4) :897-909.
  • 7Ramirez AM, Wongtrakool C, Welch T, et al. Vitamin D inhibi- tion of pro-fibrotic effects of transforming growth factor betal in lung fibroblasts and epithelial cells [ J ]. J Steroid Biochem Mol Biol, 2010,118(3) :142-150.
  • 8Zhang Y, Kong J, Deb DK, et al. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system[J]. J Am Soc Nephrol, 2010,21 (6) :966-973.
  • 9Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes : carbon tetrachloride as a toxicological model [ J]. Crit Rev Toxicol, 2003,33(2) :105-136.
  • 10Baur K, Mertens JC, Schmitt J, et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor ( NR 111 ) variants on fibrosis progression rate in HCV patients [J].Liver Int, 2012,32(4) :635-643.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部